KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $3.2 billion.

  • Amgen's Income from Continuing Operations rose 1363.96% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 6560.28%. This contributed to the annual value of $4.1 billion for FY2024, which is 3910.97% down from last year.
  • Amgen's Income from Continuing Operations amounted to $3.2 billion in Q3 2025, which was up 1363.96% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Amgen's Income from Continuing Operations ranged from a high of $3.2 billion in Q3 2025 and a low of -$113.0 million during Q1 2024
  • For the 5-year period, Amgen's Income from Continuing Operations averaged around $1.6 billion, with its median value being $1.6 billion (2022).
  • In the last 5 years, Amgen's Income from Continuing Operations tumbled by 10397.75% in 2024 and then soared by 163097.35% in 2025.
  • Quarter analysis of 5 years shows Amgen's Income from Continuing Operations stood at $1.9 billion in 2021, then decreased by 14.9% to $1.6 billion in 2022, then plummeted by 52.54% to $767.0 million in 2023, then fell by 18.25% to $627.0 million in 2024, then surged by 412.92% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.7 billion during Q1 2025.